510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K071239Substantially Equivalent

Total Protein Urine/csf Gen.3

Roche Diagnostics GmbH, Indianapolis IN / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K071239 is the FDA 510(k) clearance record for TOTAL PROTEIN URINE/CSF GEN.3, a class II device, cleared for Roche Diagnostics on under FDA product code JGQ (Turbidimetric, Total Protein). FDA records list 465 510(k) clearances for Roche Diagnostics, from to . As of , FDA records show no recalls naming K071239.

Clearance record

Decision date
Received
(134 days to decision)
Product code
JGQ Turbidimetric, Total Protein
Regulation
21 CFR 862.1635
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Roche Diagnostics 9155 Hague Rd., Indianapolis IN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code JGQ

Trailing 12 months

FDA records hold no clearances under product code JGQ in the trailing twelve months.

FDA records show no clearances under product code JGQ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JGQ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260